Protective effects of different antioxidants and amrinone on vancomycin-induced nephrotoxicity

dc.contributor.authorCelik, I
dc.contributor.authorCihangiroglu, M
dc.contributor.authorIlhan, N
dc.contributor.authorAkpolat, N
dc.contributor.authorAkbulut, HH
dc.date.accessioned2026-08-12T17:29:10Z
dc.date.issued2005
dc.departmentFırat Üniversitesi
dc.description.abstractWe have studied the effects of three antioxidants and amrinone, an inotropic agent, against vancomycin-induced nephrotoxicity in rats by investigating renal function and morphology. Thirty adult female Sprague Dawley rats (168-234 g) were divided into six groups. A saline-treated group served as control. The other five groups were treated for 7 days with vancomycin alone or in combination with alpha-lipoic acid, Ginkgo biloba extract 761, melatonin or amrinone. On day 8, all the rats were sacrificed by decapitation, kidney tissues were excised immediately and blood and kidney samples were collected. Blood urea and creatinine, kidney tissue malondialdehyde levels, and kidney superoxide dismutase and glutathione (GSH) peroxidase activities were measured. The kidneys were also examined for histological changes. Vancomycin administration led to increased urea, creatinine and malondialdehyde levels and decreased superoxide dismutase and GSH peroxidase activities. Co-administration of alpha-lipoic acid, Ginkgo biloba extract, melatonin or amrinone with vancomycin prevented the increases in the urea, creatinine and melondialdehyde levels and also resulted in higher superoxide dismutase and GSH peroxidase activities. The antioxidants and AMR improved the renal pathology compared to rats treated with vancomycin alone (P < 0.05). These results indicate that the three antioxidants and amrinone have potential protective effects against vancomycin-induced nephrotoxicity, which might in part be due to inhibition of free oxygen radical production. Amrinone was the most effective drug as judged on the basis of the pathological findings.
dc.identifier.doi10.1111/j.1742-7843.2005.pto_153.x
dc.identifier.endpage332
dc.identifier.issn1742-7835
dc.identifier.issn1742-7843
dc.identifier.issue5
dc.identifier.orcid0000-0002-2604-3776
dc.identifier.orcid0000-0002-0208-8929
dc.identifier.orcid0000-0002-9138-2117
dc.identifier.pmid16236146
dc.identifier.scopus2-s2.0-27744497015
dc.identifier.scopusqualityQ2
dc.identifier.startpage325
dc.identifier.urihttps://doi.org/10.1111/j.1742-7843.2005.pto_153.x
dc.identifier.urihttps://hdl.handle.net/11508/55598
dc.identifier.volume97
dc.identifier.wosWOS:000232664200010
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofBasic & Clinical Pharmacology & Toxicology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260511
dc.subjectGentamicin-Induced Nephrotoxicity
dc.subjectAcute-Renal-Failure
dc.subjectAlpha-Lipoic Acid
dc.subjectOxidative Stress
dc.subjectTobramycin Nephrotoxicity
dc.subjectSuperoxide-Dismutase
dc.subjectFree-Radicals
dc.subjectMelatonin
dc.subjectRats
dc.subjectInjury
dc.titleProtective effects of different antioxidants and amrinone on vancomycin-induced nephrotoxicity
dc.typeArticle

Dosyalar